Ahmed, A. T., Weinshilboum, R., & Frye, M. A. (2018). Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder. Clin Pharmacol Ther.
Citação norma ChicagoAhmed, Ahmed T., Richard Weinshilboum, and Mark A. Frye. "Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder." Clin Pharmacol Ther 2018.
MLA citiranjeAhmed, Ahmed T., Richard Weinshilboum, and Mark A. Frye. "Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder." Clin Pharmacol Ther 2018.
Opozorilo: Ti citati niso vedno 100% točni.